Lantheus Holdings Inc.

NASDAQ: LNTH
Share price (7/25/25): $72.93
Market cap (7/25/25): $5.046 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 124 pages Agreement and Plan of Merger by and Among: Lantheus Medical Imaging, Inc., as Parent; Project Hazel Merger Sub, Inc., as Merger Sub; Evergreen Theragnostics, Inc., as the Company; and Shareholder Representative Services LLC, as the Securityholders’ Representative and for Purposes of Section 11.2 Only, Lantheus Holdings, Inc. Dated as of January 27, 2025

from 8-K 99 pages Amended and Restated Agreement and Plan of Merger Among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc. Dated as of February 20, 2020

from 425 99 pages Amended and Restated Agreement and Plan of Merger Among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc. Dated as of February 20, 2020

from 425 96 pages Agreement and Plan of Merger Among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc. Dated as of October 1, 2019

from 8-K 96 pages Agreement and Plan of Merger Among Lantheus Holdings, Inc., Plato Merger Sub, Inc. and Progenics Pharmaceuticals, Inc. Dated as of October 1, 2019

from 10-Q/A 130 pages Amended and Restated Asset Purchase Agreement January 13, 2016

from 10-Q 130 pages Amended and Restated Asset Purchase Agreement January 13, 2016